On the rise of AI technologies for virtual screening
Cecchini, M.; Sinenka, H.
Show abstract
AI foundational models for predicting protein-ligand interactions and binding affinities have started to emerge. We challenged Boltz-2 on a difficult dataset constructed on ten ultra-large virtual screening hit lists of pharmacologically relevant targets with in vitro binding assays. We show that Boltz-2 is the best classifier, with a success rate twice that of any other rescoring strategy. Ligand classifications by Boltz-2 are straightforward, accurate, efficient and robust, opening to million-compound accurate rankings on commodity resources.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Deep Generative Design with 3D Pharmacophoric Constraints 96%
- Transfer learning enables discovery of sub-micromolar antibacterials for ESKAPE pathogens from ultra-large chemical spaces 95%
- Structure-Aware Dual-Target Drug Design through Collaborative Learning of Pharmacophore Combination and Molecular Simulation 95%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.